Name:
37394265.pdf
Size:
372.5Kb
Format:
PDF
Description:
Identified with Open Access button
Affiliation
The Christie NHS Foundation Trust, Manchester, UK; The University of Manchester, Manchester, UKIssue Date
2023
Metadata
Show full item recordAbstract
NoneCitation
Rembielak A, Budrukkar A, Kron T. Function Preservation with Brachytherapy: Reviving the Art. Clinical oncology (Royal College of Radiologists (Great Britain)). 2023 Aug;35(8):485-8. PubMed PMID: 37394265. Epub 2023/07/03. eng.Journal
Clinical OncologyDOI
10.1016/j.clon.2023.06.010PubMed ID
37394265Additional Links
https://dx.doi.org/10.1016/j.clon.2023.06.010Type
otherLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.clon.2023.06.010
Scopus Count
Collections
Related articles
- Erectile function after permanent prostate brachytherapy.
- Authors: Merrick GS, Butler WM, Galbreath RW, Stipetich RL, Abel LJ, Lief JH
- Issue date: 2002 Mar 15
- Five-year potency preservation after iodine-125 prostate brachytherapy.
- Authors: Nishimura S, Yorozu A, Ohashi T, Sakayori M, Yagi Y, Nishiyama T, Saito S, Shiraishi Y, Yoshida K, Toya K, Shigematsu N
- Issue date: 2014 Oct
- Assessment of sexual function in Japanese men with prostate cancer undergoing permanent brachytherapy without androgen deprivation therapy: Analysis from the Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation database.
- Authors: Okihara K, Yorozu A, Saito S, Tanaka N, Koga H, Higashide S, Kikuchi T, Nakano M
- Issue date: 2017 Jul
- Re: Five-year potency preservation after iodine-125 prostate brachytherapy.
- Authors: Seftel AD
- Issue date: 2015 Jan
- Ocular complications following I-125 brachytherapy for choroidal melanoma.
- Authors: Wen JC, Oliver SC, McCannel TA
- Issue date: 2009 Jun